Guidelines for the sale of dietary supplements have been relaxed by the US FDA

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1222, 2000-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical guidelines for the clinical use of dietary supplements and nutraceuticals have been released

Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Amendments to the requirements for brandname-drug patents have been proposed by the US FDA

Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The endpoints used by the US FDA to approve new oncology drug applications have been summarised

Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Recommendations against the use of betacarotene supplements for the prevention of cardiovascular disease or cancer have been published by the US Preventive Services Task Force

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 431, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Consensus guidelines for the treatment of acute decompensated heart failure (HF) in the emergency-department setting of US GPO hospitals have been developed

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite